GlassScriptPhysician profile
Casey D Ziegler
NPI 1730849712
$4,434.91
in general payments reported to CMS, 2019-2025
22 companies · $2,964 in 2025
The $2,964 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $248 · 2023: $169 · 2024: $1,054 · 2025: $2,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,325 · Travel and Lodging: $1,862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,325.39 |
| Travel and Lodging | $1,861.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,698.97 | 2024-2025 | Intracept, Wavewriter Alpha Prime 16, Infinion 16 |
| Curonix LLC | $1,049.76 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $296.16 | 2023-2025 | Xtampza, Belbuca |
| Abbvie INC. | $210.34 | 2023-2025 | |
| Averitas Pharma INC. | $164.84 | 2023-2025 | Qutenza |
| Stryker Corporation | $156.21 | 2025 | Multigen 2, Mild Device Kit |
| Tersera Therapeutics LLC | $122.59 | 2024-2025 | Prialt |
| Emd Serono, INC. | $111.85 | 2022 | |
| Pfizer INC. | $98.61 | 2023-2024 | |
| Scilex Pharmaceuticals INC. | $85.92 | 2023-2024 | Ztlido |
| Tonix Medicines, INC. | $84.05 | 2025 | |
| Medtronic, INC. | $78.80 | 2024-2025 | Inceptiv, Synchromedii |
| Mml US, INC. | $54.16 | 2025 | Reactiv8 |
| Lilly USA, LLC | $49.16 | 2022 | |
| Genzyme Corporation | $33.99 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $24.53 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.36 | 2024 | Relistor |
| Nalu Medical, INC. | $23.18 | 2024 | Nalu Neurostimulation System |
| Kyowa Kirin, INC. | $18.55 | 2022 | |
| Corium, LLC | $17.49 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.86 | 2022 | |
| Hikma Pharmaceuticals USA | $15.53 | 2024 | Kloxxado |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Ziegler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.